Estimates of effective dose to pediatric patients undergoing enteric and venous access procedures

Kiara Govia1, Bairbre L Connolly, Karen E Thomas

  • 1Division of Image Guided Therapy in the Department of Diagnostic Imaging, Hospital for Sick Children, 555 University Ave., Toronto, ON, Canada M5G 1X8.

Insights

Pediatric effective doses from enteric and venous access procedures are typically low. However, complex cases can result in radiation exposure levels similar to pediatric computed tomography scans.

Area of Science:

  • Medical Imaging
  • Pediatric Radiology
  • Radiation Dosimetry

Background:

  • Fluoroscopy is essential for pediatric enteric and venous access procedures.
  • Accurate estimation of effective dose is crucial for patient safety and radiation protection.

Purpose of the Study:

  • To determine the range of effective doses during common pediatric enteric and venous access procedures.
  • To develop a method for estimating effective dose based on fluoroscopy time.

Main Methods:

  • Utilized a pediatric phantom and MOSFET model to simulate nine enteric and venous access procedures.
  • Calculated age- and procedure-specific factors (mSv·min⁻¹) by normalizing effective dose to fluoroscopy time.
  • Applied these factors to 7,074 patient encounters to estimate effective doses.

Main Results:

  • Mean effective dose for venous access procedures was 0.1 mSv (range: 0.01–3.28 mSv).
  • Mean effective dose for enteric access procedures ranged from 0.3–1.7 mSv (range: 0.01–11.35 mSv).
  • Maintenance enteric procedures had approximately 50% lower doses than primary insertions.

Conclusions:

  • Effective doses for pediatric enteric and venous access procedures are generally low.
  • In complex cases, effective doses can approach levels seen in pediatric computed tomography.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...